The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy-Reference-Cited by-同舟云学术

The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy

Published:2014-05-13 Issue:11 Volume:5 Page:3622-3635
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Li Siwen¹,Qin Jingyi¹,Tian Caiping¹,Cao Jie¹,Fida Guissi¹,Wang Zhaohui¹,Chen Haiyan¹,Qian Zhiyu²,Chen Wei R³,Gu Yueqing¹

Affiliation:

1. Department of Biomedical Engineering, State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University

2. Department of Biomedical Engineering, School of Automation, Nanjing University of Aeronautics and Astronautics, Nanjing, China

3. Department of Engineering and Physics, University of Central Oklahoma, Edmond, Oklahoma

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucoadhesive Carrier-Mediated Oral Co-delivery of Bcl2 Inhibitors Improves Gastric Cancer Treatment;ACS Applied Materials & Interfaces;2023-12-29

2. Self-assembled lipid–prodrug nanoparticles;Nature Reviews Bioengineering;2023-06-28

3. Lysophosphatidylcholine-DHA Specifically Induces Cytotoxic Effects of the MDA-MB-231 Human Breast Cancer Cell Line In Vitro—Comparative Effects with Other Lipids Containing DHA;Nutrients;2023-04-29

4. Promising Effects of N-Docosahexaenoyl Ethanolamine in Breast Cancer: Molecular and Cellular Insights;Molecules;2023-04-25

5. Delivery of artemether for the treatment of colorectal cancer liver metastases according to a sugar-coated cannonball strategy;Journal of Drug Delivery Science and Technology;2023-04